{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:44:27Z","timestamp":1765349067606,"version":"3.46.0"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Glycosylation of viral surface proteins by host cell factors is one strategy paramyxoviruses employ to evade the host\u2019s immune system during infection. Viral glycosylation thus has the potential for innate and adaptive immune modulation. However, an adequate assessment of the effects glycosylation has on immune recognition and response for two important paramyxoviruses, Measles virus (MeV) and Mumps virus (MuV), is lacking. This review aims to provide a comparison of epitope-site sequence changes in the surface glycoproteins MeV-H, MeV-F, MuV-HN, and MuV-F across different wild type and vaccine strains of measles and mumps. Such changes may alter glycosylation patterns at antigenic sites, thus altering the virus\u2019 efficiency to induce an immune response as well. Further investigation of measles and mumps viral glycosylation studies will aid the development of specific therapeutics that modulate viral glycosylation during immune diseases, viral infections, and oncolytic treatments. Moreover, determining how glycosylation affects measles and mumps immune responses may pave the way for the development of novel vaccine strains for the improved immunogenicity and immune durability of measles and mumps vaccines.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1716829","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:41:06Z","timestamp":1765348866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycosylation as a strategic mechanism for measles virus and mumps virus immune evasion"],"prefix":"10.3389","volume":"16","author":[{"given":"Catalina","family":"Galvan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coviro.2020.05.009","article-title":"Waning immunity and re-emergence of measles and mumps in the vaccine era","volume":"40","author":"Yang","year":"2020","journal-title":"Curr Opin Virol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"eaao5945","DOI":"10.1126\/scitranslmed.aao5945","article-title":"Vaccine waning and mumps re-emergence in the United States","volume":"10","author":"Lewnard","year":"2018","journal-title":"Sci Trans Med"},{"key":"B3","unstructured":"Measles in Ontario\n          \n          \n          \n          2025"},{"key":"B4","unstructured":"Continued increase in measles cases in the Western Pacific Region\n          \n          \n          \n          2025"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41182-022-00411-w","article-title":"Mumps outbreak in university students: first detection of mumps virus genotype F in Borneo","volume":"50","author":"Fong","year":"2022","journal-title":"Trop Med Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06125-11","article-title":"Recent mumps outbreaks in vaccinated populations: no evidence of immune escape","volume":"86","author":"Rubin","year":"2012","journal-title":"J Virol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2024.09.011","article-title":"Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: A descriptive study using a population-based database in Japan","volume":"53","author":"Sato","year":"2025","journal-title":"Am J infection control"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.07.034","article-title":"Preventing measles in immunosuppressed cancer and hematopoietic cell transplantation patients: A position statement by the American society for transplantation and cellular therapy","volume":"25","author":"Pergam","year":"2019","journal-title":"Biol Blood marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.02.030","article-title":"Differential durability of immune responses to measles and mumps following MMR vaccination","volume":"37","author":"Kennedy","year":"2019","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108912","article-title":"Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents","volume":"234","author":"Riggenbach","year":"2022","journal-title":"Clin Immunol (Orlando Fla.)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"126143","DOI":"10.1016\/j.vaccine.2024.07.044","article-title":"Characteristics of reported mumps cases in the United States: 2018-2023","volume":"42","author":"Tappe","year":"2024","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2017.09.024","article-title":"Emergent lineages of mumps virus suggest the need for a polyvalent vaccine","volume":"66","author":"May","year":"2018","journal-title":"Int J Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.06.033","article-title":"Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines","volume":"40","author":"Gambrell","year":"2022","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf188","article-title":"Patterns of decline in measles, mumps, and rubella neutralizing antibodies and protection levels through 10 years after a second and third dose of MMR vaccine","volume":"12","author":"Lutz","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1871296","article-title":"Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study","volume":"17","author":"Bianchi","year":"2021","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104849","article-title":"In vitro inhibition of mumps virus replication by favipiravir (T-705)","volume":"180","author":"Lawson","year":"2020","journal-title":"Antiviral Res"},{"key":"B17","article-title":"Measles control\u2013can measles virus inhibitors make a difference","volume":"10","author":"Plemper","year":"2009","journal-title":"Curr Opin investigational Drugs (London England: 2000)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2025071332","DOI":"10.1542\/peds.2025-071332","article-title":"What\u2019s old is new again: measles","volume":"155","author":"Naureckas Li","year":"2025","journal-title":"Pediatrics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1708162","article-title":"High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2\u20135 years from kindergartens in Jiangsu Province, China","volume":"16","author":"Sun","year":"2020","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1128\/JVI.05899-11","article-title":"Measles virus C protein interferes with Beta interferon transcription in the nucleus","volume":"86","author":"Sparrer","year":"2012","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.13.7635-7644.2003","article-title":"STAT protein interference and suppression of cytokine signal transduction by measles virus V protein","volume":"77","author":"Palosaari","year":"2003","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0161793","DOI":"10.1371\/journal.pone.0161793","article-title":"Mumps virus induces protein-kinase-R-dependent stress granules, partly suppressing type III interferon production","volume":"11","author":"Hashimoto","year":"2016","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01037-17","article-title":"Mumps virus SH protein inhibits NF-\u03baB activation by interacting with tumor necrosis factor receptor 1, interleukin-1 receptor 1, and toll-like receptor 3 complexes","volume":"91","author":"Franz","year":"2017","journal-title":"J Virol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.11.6385-6393.2003","article-title":"STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling","volume":"77","author":"Ulane","year":"2003","journal-title":"J Virol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00831-08","article-title":"STAT2 is a primary target for measles virus V protein-mediated alpha\/beta interferon signaling inhibition","volume":"82","author":"Ramachandran","year":"2008","journal-title":"J Virol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.01.004","article-title":"Interferons and viruses: an evolutionary arms race of molecular interactions","volume":"36","author":"Hoffmann","year":"2015","journal-title":"Trends Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5501\/wjv.v2.i2.57","article-title":"Paramyxovirus evasion of innate immunity: Diverse strategies for common targets","volume":"2","author":"Audsley","year":"2013","journal-title":"World J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11121419","article-title":"Nipah and hendra viruses: deadly zoonotic paramyxoviruses with the potential to cause the next pandemic","volume":"11","author":"Gazal","year":"2022","journal-title":"Pathog (Basel Switzerland)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13010124","article-title":"Nipah virus: A zoonotic threat re-emerging in the wake of global public health challenges","volume":"13","author":"Branda","year":"2025","journal-title":"Microorganisms"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3201\/eid1602.090780","article-title":"Hendra virus outbreak with novel clinical features, Australia","volume":"16","author":"Field","year":"2010","journal-title":"Emerging Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01999","article-title":"Mumps vaccines: current challenges and future prospects","volume":"11","author":"Almansour","year":"2020","journal-title":"Front Microbiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102535","article-title":"How viruses hijack and modify the secretory transport pathway","volume":"10","author":"Hassan","year":"2021","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1005445","DOI":"10.1371\/journal.ppat.1005445","article-title":"Multiple novel functions of henipavirus O-glycans: the first O-glycan functions identified in the paramyxovirus family","volume":"12","author":"Stone","year":"2016","journal-title":"PloS Pathog"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.10.4878-4889.2006","article-title":"N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry","volume":"80","author":"Aguilar","year":"2006","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal transduction targeted Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2060464","article-title":"Glycosylation of viral proteins: Implication in virus-host interaction and virulence","volume":"13","author":"Feng","year":"2022","journal-title":"Virulence"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2021.151186","article-title":"Advances in understanding N-glycosylation structure, function, and regulation in health and disease","volume":"100","author":"Esmail","year":"2021","journal-title":"Eur J Cell Biol"},{"key":"B38","volume-title":"Essentials of Glycobiology","author":"Varki","year":"2022"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3RI0116-021R","article-title":"Glycobiology simplified: diverse roles of glycan recognition in inflammation","volume":"99","author":"Schnaar","year":"2016","journal-title":"J leukocyte Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(86)90312-0","article-title":"The predicted primary structure of the measles virus hemagglutinin","volume":"150","author":"Alkhatib","year":"1986","journal-title":"Virology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-11-2679","article-title":"Glycosylation of measles virus haemagglutinin protein in infected cells","volume":"72","author":"Ogura","year":"1991","journal-title":"J Gen Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/v14061335","article-title":"Exploring the mumps virus glycoproteins: A review","volume":"14","author":"Frost","year":"2022","journal-title":"Viruses"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00344-19","article-title":"Molecular mechanism of the flexible glycan receptor recognition by mumps virus","volume":"93","author":"Kubota","year":"2019","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/plants11030428","article-title":"Critical determinants in ER-golgi trafficking of enzymes involved in glycosylation","volume":"11","author":"Zhang","year":"2022","journal-title":"Plants (Basel Switzerland)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(88)90681-2","article-title":"Intracellular processing of mumps virus glycoproteins","volume":"165","author":"Yamada","year":"1988","journal-title":"Virology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00050-20","article-title":"Lysosome-associated membrane proteins support the furin-mediated processing of the mumps virus fusion protein","volume":"94","author":"Ueo","year":"2020","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1010949","DOI":"10.1371\/journal.ppat.1010949","article-title":"SNARE protein USE1 is involved in the glycosylation and the expression of mumps virus fusion protein and important for viral propagation","volume":"18","author":"Liu","year":"2022","journal-title":"PloS Pathog"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638573","article-title":"The importance of glycans of viral and host proteins in enveloped virus infection","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/BF01321055","article-title":"Intracellular processing and antigenic maturation of measles virus hemagglutinin protein","volume":"136","author":"Hu","year":"1994","journal-title":"Arch Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-3-705","article-title":"Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein","volume":"76","author":"Hu","year":"1995","journal-title":"J Gen Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.47.2.354-362.1983","article-title":"Posttranslational modification and intracellular transport of mumps virus glycoproteins","volume":"47","author":"Herrler","year":"1983","journal-title":"J Virol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(88)90681-2","article-title":"Intracellular processing of mumps virus glycoproteins","volume":"165","author":"Yamada","year":"2004","journal-title":"Virology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00773-15","article-title":"Novel functions of hendra virus G N-glycans and comparisons to nipah virus","volume":"89","author":"Bradel-Tretheway","year":"2015","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1038\/s41467-023-39278-8","article-title":"Structure and antigenicity of divergent Henipavirus fusion glycoproteins","volume":"14","author":"Isaacs","year":"2023","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1091","article-title":"Updated resources for exploring experimentally-determined PDB structures and Computed Structure Models at the RCSB Protein Data Bank","volume":"53","author":"Burley","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/v8080216","article-title":"Measles virus hemagglutinin protein epitopes: the basis of antigenic stability","volume":"8","author":"Tahara","year":"2016","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-77-10-2491","article-title":"Antigenic and genetic variation of the HN protein of mumps virus strains","volume":"77","author":"Yates","year":"1996","journal-title":"J Gen Virol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05258-0","article-title":"Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer","volume":"176","author":"Cohen","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-023-02415-3","article-title":"Altered expression of Sialyl Lewis X in experimental models of Parkinson\u2019s disease","volume":"102","author":"Nunes","year":"2024","journal-title":"J Mol Med (Berlin Germany)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-1702(00)00254-9","article-title":"Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein","volume":"74","author":"Cusi","year":"2001","journal-title":"Virus Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1155\/2001\/910649","article-title":"Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine","volume":"12","author":"Bakker","year":"2001","journal-title":"Can J Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.05.006","article-title":"Slow clearance of measles virus RNA after acute infection","volume":"39","author":"Riddell","year":"2007","journal-title":"J Clin Virol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.2.910-920.2001","article-title":"Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage","volume":"75","author":"Parks","year":"2001","journal-title":"J Virol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb08121.x","article-title":"Infectious measles virus from cloned cDNA","volume":"9","author":"Ballart","year":"1990","journal-title":"EMBO J"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21535","article-title":"Genetic characterization of Chinese measles vaccines by analysis of complete genomic sequences","volume":"81","author":"Zhang","year":"2009","journal-title":"J Med Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(94)90025-6","article-title":"Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains","volume":"31","author":"Rota","year":"1994","journal-title":"Virus Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11262-007-0173-1","article-title":"Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures","volume":"36","author":"Borges","year":"2008","journal-title":"Virus Genes"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.01429-16","article-title":"Complete genome sequence of mumps virus isolated from karnataka state, India","volume":"5","author":"Vaidya","year":"2017","journal-title":"Genome announcements"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.013946-0","article-title":"Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2","volume":"90","author":"Chambers","year":"2009","journal-title":"J Gen Virol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1629-y","article-title":"Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis","volume":"133","author":"Morfopoulou","year":"2017","journal-title":"Acta neuropathologica"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1009","article-title":"Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain","volume":"287","author":"Amexis","year":"2001","journal-title":"Virology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2003.11.002","article-title":"Genetic characterization of a mumps virus isolate during passaging in the amniotic cavity of embryonated chicken eggs","volume":"99","author":"Ivancic","year":"2004","journal-title":"Virus Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122402","article-title":"Impact of glycosylation on viral vaccines","volume":"342","author":"Lembo","year":"2024","journal-title":"Carbohydr polymers"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15909","article-title":"Recent advances on smart glycoconjugate vaccines in infections and cancer","volume":"289","author":"Anderluh","year":"2022","journal-title":"FEBS J"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e2404053121","DOI":"10.1073\/pnas.2404053121","article-title":"Structure-based design of glycoprotein subunit vaccines for mumps","volume":"121","author":"Loomis","year":"2024","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c02345","article-title":"Exploring the potential of chemical inhibitors for targeting post-translational glycosylation of coronavirus (SARS-coV-2)","volume":"7","author":"Tripathi","year":"2022","journal-title":"ACS omega"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.10.009","article-title":"Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus","volume":"24","author":"Atrasheuskaya","year":"2006","journal-title":"Vaccine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4161\/hv.22132","article-title":"Horizontal transmission of live vaccines","volume":"9","author":"Kulkarni","year":"2013","journal-title":"Hum Vaccines immunotherapeutics"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.055","article-title":"Horizontal transmission of the Leningrad-Zagreb mumps vaccine strain: a report of six symptomatic cases of parotitis and one case of meningitis","volume":"30","author":"Atrasheuskaya","year":"2012","journal-title":"Vaccine"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwr087","article-title":"Since there are PAMPs and DAMPs, there must be SAMPs? Glycan \u201cself-associated molecular patterns\u201d dampen innate immunity, but pathogens can mimic them","volume":"21","author":"Varki","year":"2011","journal-title":"Glycobiology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.005","article-title":"Myeloid C-type lectin receptors in innate immune recognition","volume":"57","author":"Reis e Sousa","year":"2024","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2807","article-title":"Structural basis of recognition of interferon-\u03b1 receptor by tyrosine kinase 2","volume":"21","author":"Wallweber","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13092176","article-title":"Pattern recognition receptors (PRRs) expression and activation in COVID-19 and long COVID: from SARS-coV-2 escape mechanisms to emerging PRR-targeted immunotherapies","volume":"13","author":"Maddaloni","year":"2025","journal-title":"Microorganisms"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2014.00148","article-title":"The lectin pathway of complement and rheumatic heart disease","volume":"2","author":"Beltrame","year":"2015","journal-title":"Front Pediatr"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2011.58","article-title":"C-type lectin receptor-induced NF-\u03baB activation in innate immune and inflammatory responses","volume":"9","author":"Kingeter","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1613254114","article-title":"C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells","volume":"114","author":"Troegeler","year":"2017","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2022.088","article-title":"Involvement of IKK\/IkB\u03b1\/NF-kB p65 Signaling into the Regulative Effect of Engeletin on MUC5AC Mucin Gene Expression in Human Airway Epithelial Cells","volume":"30","author":"Hossain","year":"2022","journal-title":"Biomolecules Ther"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01760","article-title":"Gal-3BP negatively regulates NF-\u03baB signaling by inhibiting the activation of TAK1","volume":"10","author":"Hong","year":"2019","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.05.021","article-title":"Nuclear factor (NF)-\u03baB controls expression of the immunoregulatory glycan-binding protein galectin-1","volume":"48","author":"Toscano","year":"2011","journal-title":"Mol Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.108","article-title":"Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27","volume":"25","author":"Zheng","year":"2015","journal-title":"Cell Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698420","article-title":"Siglec-H-deficient mice show enhanced type I IFN responses, but do not develop autoimmunity after influenza or LCMV infections","volume":"12","author":"Szumilas","year":"2021","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e66266","DOI":"10.1371\/journal.pone.0066266","article-title":"Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain","volume":"8","author":"Bloem","year":"2013","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/v14122641","article-title":"Measles virus-induced host immunity and mechanisms of viral evasion","volume":"14","author":"Amurri","year":"2022","journal-title":"Viruses"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/v14051107","article-title":"Type I and type II interferon antagonism strategies used by paramyxoviridae: previous and new discoveries, in comparison","volume":"14","author":"Pisanelli","year":"2022","journal-title":"Viruses"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218439","article-title":"Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma","volume":"80","author":"Ross","year":"2021","journal-title":"Ann rheumatic Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwae082","article-title":"Interactions that define the arrangement of sugar-binding sites in BDCA-2 and dectin-2 dimers","volume":"34","author":"Liu","year":"2024","journal-title":"Glycobiology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.011","article-title":"Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation","volume":"152","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwaa083","article-title":"The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19","volume":"30","author":"Laine","year":"2020","journal-title":"Glycobiology"},{"key":"B103","article-title":"Alpha glucosidase inhibitors","volume-title":"StatPearls","author":"Akmal","year":"2025"},{"key":"B104","first-page":"274","article-title":"Pharmacotherapy of gaucher disease: current and future options","volume":"43","author":"Bennett","year":"2018","journal-title":"P T: peer-reviewed J formulary Manage"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e001230","DOI":"10.1136\/bmjdrc-2020-001230","article-title":"Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes","volume":"8","author":"Singh","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B106","doi-asserted-by":"publisher","first-page":"16019","DOI":"10.1038\/mto.2016.19","article-title":"Recombinant mumps virus as a cancer therapeutic agent","volume":"3","author":"Ammayappan","year":"2016","journal-title":"Mol Ther oncolytics"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030544","article-title":"Measles virus as an oncolytic immunotherapy","volume":"13","author":"Engeland","year":"2021","journal-title":"Cancers"},{"key":"B108","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.1038\/s41598-023-42305-9","article-title":"Anti-tumor activity of a recombinant measles virus against canine lung cancer cells","volume":"13","author":"Tamura","year":"2023","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395187","article-title":"Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy","volume":"15","author":"Qin","year":"2024","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","article-title":"Glycosylation in the era of cancer-targeted therapy: where are we heading","volume":"36","author":"Mereiter","year":"2019","journal-title":"Cancer Cell"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120612","article-title":"Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells","volume":"128","author":"Stanczak","year":"2018","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1992.8.165","article-title":"Glucosidase inhibitors for treatment of HIV-1 infection","volume":"8","author":"Ratner","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18734-0","article-title":"Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin","volume":"84","author":"Hart","year":"2003","journal-title":"J Gen Virol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910577","article-title":"Glycan-lectin interactions in cancer and viral infections and how to disrupt them","volume":"22","author":"Kremsreiter","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41419-025-07517-z","article-title":"Leveraging glycosylation for early detection and therapeutic target discovery in pancreatic cancer","volume":"16","author":"Pienkowski","year":"2025","journal-title":"Cell Death Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188838","article-title":"The role of N-glycosylation in B-cell biology and IgG activity. The aspects of autoimmunity and anti-inflammatory therapy","volume":"14","author":"Trzos","year":"2023","journal-title":"Front Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01074-1","article-title":"Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection","volume":"20","author":"Pinho","year":"2023","journal-title":"Cell Mol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1716829\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:41:08Z","timestamp":1765348868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1716829\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":117,"alternative-id":["10.3389\/fimmu.2025.1716829"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1716829","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"article-number":"1716829"}}